John A. Scarlett's most recent trade in Geron Corp. was a trade of 12,500 Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on Feb. 27, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.77 per share. | 27 Feb 2025 | 12,500 | 12,500 (0%) | 0% | 1.8 | 22,063 | Common Stock |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 2,457,000 | 2,457,000 | - | - | Stock Option (right to buy) | |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 410,000 | 410,000 | - | - | Restricted Stock Units | |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 1,000,000 | 1,000,000 | - | - | Employee Stock Option (right to buy) | |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. | 04 Jun 2024 | 600,000 | 600,000 (0%) | 0% | 2.5 | 1,524,000 | Common Stock |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 600,000 | 0 | - | - | Stock Option (right to buy) | |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 04 Jun 2024 | 600,000 | 600,000 (0%) | 0% | 4 | 2,400,000 | Common Stock |
Geron Corp. | Scarlett A. John | Director, CHAIRMAN, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 3,000,000 | 3,000,000 | - | - | Employee Stock Option (Right to Buy) | |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 1,750,000 | 1,750,000 | - | - | Employee Stock Option (Right to buy) | |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 08 Feb 2023 | 446,668 | 446,668 (0%) | 0% | 1.5 | 670,002 | Common Stock |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 3.00 per share. | 08 Feb 2023 | 446,668 | 0 (0%) | 0% | 3 | 1,340,004 | Common Stock |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2023 | 446,668 | 0 | - | - | Employee Stock Option (right to buy) | |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 3.03 per share. | 08 Feb 2023 | 446,666 | 0 (0%) | 0% | 3.0 | 1,353,398 | Common Stock |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 08 Feb 2023 | 446,666 | 446,666 (0%) | 0% | 1.5 | 669,999 | Common Stock |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 3.08 per share. | 08 Feb 2023 | 446,666 | 0 (0%) | 0% | 3.1 | 1,375,731 | Common Stock |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 08 Feb 2023 | 446,666 | 446,666 (0%) | 0% | 1.5 | 669,999 | Common Stock |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2023 | 446,666 | 0 | - | - | Employee Stock Option (right to buy) | |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2023 | 446,666 | 0 | - | - | Employee Stock Option (right to buy) | |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 2,100,000 | 2,100,000 | - | - | Employee Stock Option (Right to buy) | |
CytomX Therapeutics Inc | John A. Scarlett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
Geron Corp. | John A. Scarlett | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 600,000 | 600,000 | - | - | Employee Stock Option (Right to buy) | |
CytomX Therapeutics Inc | John A. Scarlett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |